Login
Toggle navigation
Videos
Categories
Trending
I Assess Investing In An Entrepreneu|Semyon Dukach,Managing Partner,One Way Ventures
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Managing Partner at One Way Ventures.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Unveiling the Dynamic Tech Ecosystem Forged by the Mining Sector: Insights from Norcat CEO, Don Duval | Don Duval - Chief Executive Officer of NORCAT
00:10:00
AGCO CEO Discusses Grain Price Surge Amid Ukraine War | ERIC HANSOTIA - Chairman, President & CEO of AGCO Corp
00:10:00
lifelong learner and developer of talent|James Currier,General Partner,NFX
00:10:00
Assembled a team of senior operators and investors|Arra Malekzadeh,Partner,Craft Ventures
00:10:00
The Intersection of Effective Altruism and Long-Termism: Philosophical Perspectives|Matthew Lutz,Professor,Wuhan University
00:10:00
Allies investment syndicate that has invested $110M|Lorenzo Thione,Managing Director,Gaingels
00:10:00
Insider Tips on Investor Relations with Wendy Webb | Wendy Webb, independent director at ABM
00:10:00
Revolutionizing Medicine: Insights from Thomas Schinecker of Roche | Thomas Schinecker - CEO, Roche
00:10:00
Valera Rocks Prepares for ASX IPO with Advanced Exploration Projects in NSW and WA
00:10:00
Talisker's Vision: Aiming for Tier One Gold Discoveries
00:10:00
“CCLS 40th Anniversary Global Law, Economics and Finance (IGLEF) Lecture: Dr. Garry Gabison on Game Theory in Sovereign Debt Restructuring”
00:10:00
Johan Strid, CEO of Prevas AB, presentation at the 2021 annual meeting focused on strategic initiatives and company performance.